Dr. Bivona is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1600 Divisadero St
Fl 1674
San Francisco, CA 94143Phone+1 917-612-6813- Is this information wrong?
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2007 - 2011
- Brigham and Women's HospitalResidency, Internal Medicine, 2005 - 2007
- New York University School of MedicineClass of 2005
Certifications & Licensure
- CA State Medical License 2012 - 2025
- NY State Medical License 2007 - 2012
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- Unlocking the EGFR-mediated epitranscriptome: A pathway to novel therapies.Gencel-Augusto, J., Bivona, T.> ;Molecular Cell. 2023 Dec 7
- 3 citationsThe role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance.Deborah R Caswell, Philippe Gui, Manasi K Mayekar, Emily K Law, Oriol Pich, Chris Bailey, Jesse Boumelha, D Lucas Kerr, Collin M Blakely, Tadashi Manabe, Carlos Martin...> ;Nature Genetics. 2024 Jan 1
- 4 citationsLong Non-Coding RNAs as Emerging Targets in Lung Cancer.Jovanka Gencel-Augusto, Wei Wu, Trever G Bivona> ;Cancers. 2023 Jun 10
- Join now to see all
Journal Articles
- Aurora Kinase A Drives the Evolution of Resistance to Third-Generation EGFR Inhibitors in Lung CancerVictoria E Wang, Collin M Blakely, Trever G Bivona, Andrei Goga, Nature
- Pathologic Complete Response to Neoadjuvant Crizotinib in a Lung Adenocarcinoma Patient with a MET Exon 14 Skipping MutationJulia K Rotow, Trever G Bivona, Collin M Blakely, Clinical Lung Cancer
- RAS Nucleotide Cycling Underlies the SHP2 Phosphatase Dependence of Mutant BRAF-, NF1- and RAS-Driven CancersTrever Bivona, MD, Nature
Authored Content
- Pathologic Complete Response to Neoadjuvant Crizotinib in a Lung Adenocarcinoma Patient with a MET Exon 14 Skipping MutationNovember 2018
Press Mentions
- Damon Runyon Cancer Research Foundation Awards over $4.1 Million to Exceptional Early-Career ScientistsJuly 28th, 2022
- Damon Runyon Cancer Research Foundation Awards $4.8 Million to Rising InvestigatorsJuly 15th, 2021
- Novel Structure Found in Tumor Cells May Open Door to New Kinds of Cancer TherapiesMay 11th, 2021
- Join now to see all
Hospital Affiliations
- UCSF Medical CenterSan Francisco, California
- Chinese HospitalSan Francisco, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: